Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Al Alwan, Monther ^a   Olabi, Safiah ^a   Ghebeh, Hazem ^a   Barhoush, Eman ^a   Tulbah, Asma ^a   Al Tweigeri, Taher ^a   Ajarim, Dahish ^a   Adra, Chaker ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER METASTASIS SUPPRESSOR 1 PROTEIN; FASCIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UROKINASE; ACTIN BINDING PROTEIN; BRMS1 PROTEIN, HUMAN; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; MESSENGER RNA; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; ONCOGENE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; UPREGULATION; ADULT; APOPTOSIS; BREAST TUMOR; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

ADULT; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NF-KAPPA B; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 80455150312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027339     Document Type: Article

References (53)

1. Bashyam MD, (2002) Understanding cancer metastasis: an urgent need for using differential gene expression analysis. Cancer 94: 1821-1829.
2. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, et al. (2001) Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10: 243-255, vii.
3. Fidler IJ, (2001) Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 10: 257-269 vii-viiii.
4. Nicolson GL, (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143-188.
5. Saaristo A, Karpanen T, Alitalo K, (2000) Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 19: 6122-6129.
6. Woodhouse EC, Chuaqui RF, Liotta LA, (1997) General mechanisms of metastasis. Cancer 80: 1529-1537.
7. Smith SC, Theodorescu D, (2009) Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer 9: 253-264.
8. Kim J, Yu W, Kovalski K, Ossowski L, (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353-362.
9. Mignatti P, Rifkin DB, (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195.
10. Seraj MJ, Samant RS, Verderame MF, Welch DR, (2000) Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 60: 2764-2769.
11. Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, et al. (2006) Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clin Cancer Res 12: 6702-6708.
12. Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G, (2005) Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 65: 3586-3595.
13. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, et al. (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266.
14. Jiang P, Enomoto A, Takahashi M, (2009) Cell biology of the movement of breast cancer cells: Intracellular signalling and the actin cytoskeleton. Cancer Lett.
15. Edwards RA, Bryan J, (1995) Fascins, a family of actin bundling proteins. Cell Motil Cytoskeleton 32: 1-9.
16. Duh FM, Latif F, Weng Y, Geil L, Modi W, et al. (1994) cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol 13: 821-827.
17. Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, et al. (1996) Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol 148: 593-600.
18. Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, et al. (1994) Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J Virol 68: 7320-7328.
19. Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, et al. (1997) Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 150: 543-562.
20. Yamashiro S, Yamakita Y, Ono S, Matsumura F, (1998) Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 9: 993-1006.
21. Yoder BJ, Tso E, Skacel M, Pettay J, Tarr S, et al. (2005) The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 11: 186-192.
22. Al-Alwan MM, Rowden G, Lee TD, West KA, (2001) Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 166: 338-345.
23. Tran J, Kung SK, (2007) Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells. Mol Ther 15: 1331-1339.
24. Adams JC, Schwartz MA, (2000) Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42. J Cell Biol 150: 807-822.
25. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
26. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, et al. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20: 760-769.
27. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, et al. (2005) Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 337: 355-362.
28. He W, Liu Q, Wang L, Chen W, Li N, et al. (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859.
29. Bloom HJ, Richardson WW, (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377.
30. Al-Alwan MM, Rowden G, Lee TD, West KA, (2001) The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J Immunol 166: 1452-1456.
31. Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, et al. (2006) The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia 8: 190-198.
32. Naffar-Abu-Amara S, Shay T, Galun M, Cohen N, Isakoff SJ, et al. (2008) Identification of novel pro-migratory, cancer-associated genes using quantitative, microscopy-based screening. PLoS ONE 3: e1457.
33. Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, et al. (1998) Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 65: 163-168.
34. Tong D, Czerwenka K, Sedlak J, Schneeberger C, Schiebel I, et al. (1999) Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat 56: 91-97.
35. Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, et al. (2006) Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett 235: 260-265.
36. Jezierska A, Motyl T, (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15: RA32-40.
37. Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, et al. (2006) The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res 12: 1707-1714.
38. Munshi HG, Wu YI, Ariztia EV, Stack MS, (2002) Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. J Biol Chem 277: 41480-41488.
39. Sliva D, Rizzo MT, English D, (2002) Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277: 3150-3157.
40. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr, (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
41. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, et al. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20: 1626-1638.
42. Insall RH, Machesky LM, (2009) Actin dynamics at the leading edge: from simple machinery to complex networks. Dev Cell 17: 310-322.
43. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R, (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24.
44. Bocker W, Moll R, Poremba C, Holland R, Van Diest PJ, et al. (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 82: 737-746.
45. Boecker W, Buerger H, (2003) Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 36 (Suppl 1): 73-84.
46. Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, et al. (2006) Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 12: 1533-1539.
47. Gordon LA, Mulligan KT, Maxwell-Jones H, Adams M, Walker RA, et al. (2003) Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer 106: 8-16.
48. Gilmore TD, (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241-265.
49. Onodera M, Zen Y, Harada K, Sato Y, Ikeda H, et al. (2009) Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest 89: 1261-1274.
50. Zhang S, Lin QD, Di W, (2006) Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 16: 522-531.
51. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC, (2002) Fascins, and their roles in cell structure and function. Bioessays 24: 350-361.
52. Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, et al. (2009) A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biol 30: 148-159.
53. Chen L, Yang S, Jakoncic J, Zhang JJ, Huang XY, (2010) Migrastatin analogues target fascin to block tumour metastasis. Nature 464: 1062-1066.